Terazosin
Composition
This formulation contain Terazosin as active agent
Indications
It is indicated for the treatment of benign prostatic hyperplasia (BPH) and hypertension
Side effects
dizziness, headache, drowsiness, orthostatic hypotension and nasal congestion
Precautions
used with caution in patients with a history of orthostatic hypotension, syncope, or congestive heart failure
Contraindications
It is contraindicated in patients with a known hypersensitivity to terazosin or other alpha-1 blockers
Dosage and administration
directed by a healthcare professional
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai